ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program
16. januar 2017 oppdatert av: Fondazione Don Carlo Gnocchi Onlus
ABILITY - TelerehABILITation. TechnologY-enhanced Multi-domain at Home Continuum of Care Program for People With Cognitive Impairment.
The Ability research project, funded in Italy within the Smart Cities and Smart Communities funding program (MInistry of University and Research, Operational Regional Programme, Lombardy, Axis 1, Operational Regional Programme - European Funding for Regional Development 2007-2013), aims at developing and testing the efficacy and the impact of a Personal Smart Health Community able to provide innovative trajectories for people with cognitive impairment, putting them at the core of a continuous and intertwining treatment and support from both formal (e.g. physicians) and informal (e.g. near relatives) caregivers, with special focus on home-based care.
Within this framework of the Ability project the investigators test the efficacy of the home-based motor-cognitive rehabilitation program delivered with two different approaches: the Ability platform versus the usual care program
Studieoversikt
Status
Fullført
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Faktiske)
30
Fase
- Ikke aktuelt
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
65 år til 85 år (Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- diagnosed as mild AD or MCI due to AD (Albert et al, 2011) according to DSM 5 diagnostic criteria (American Psychiatric Association, 2013);
- MMSE score >18
- school attendance (≥ 3 years).
Exclusion Criteria:
- dysmetria;
- serious deficits in visual acuity, acoustic perception, and in routine communication skills.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Ability platform program
Multi-domain at home rehabilitation program delivered through the Ability platform.
|
The Ability program is an at home participant-tailored and technology-enhanced platform a) delivering tablet-based intensive (five days/a week for six weeks) motor and cognitive activities; b) monitoring from remote vital and physical health parameters (i.e., weight, Heart Rate, O2 saturation, daily steps, sleep activity).
|
|
Aktiv komparator: Usual care program
Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)
|
Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
activities of daily living
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Activities of Daily Living Inventory (ADCS/ADL)
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
behavioral symptoms
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Neuropsychiatric Inventory (NPI) score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
cognitive domain (long-term memory)
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Free and Cued Selective Recall Test (FCSRT) score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
cognitive domain (language)
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Fluency score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
cognitive domain (frontal-executive functions)
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Trail Making Test (TMT) score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
quality of life
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Dementia Quality of Life (D-QoL) Instrument
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
coping strategies
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
global cognitive level
Tidsramme: change from baseline after 12 months (aMCI/AD subjects)
|
Montreal Cognitive Asssessment (MoCA) score
|
change from baseline after 12 months (aMCI/AD subjects)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
activities of daily living
Tidsramme: change from baseline after 12 months (aMCI/AD subjects)
|
Activities of Daily Living Inventory (ADCS/ADL)
|
change from baseline after 12 months (aMCI/AD subjects)
|
|
conversion rate MCI versus AD
Tidsramme: change from baseline after 12 months (aMCI subjects)
|
conversion rate score
|
change from baseline after 12 months (aMCI subjects)
|
|
cognitive domain - long term memory
Tidsramme: change from baseline after 12 months (aMCI/AD subjects)
|
Free and Cued Selective Recall Test (FCSRT) score
|
change from baseline after 12 months (aMCI/AD subjects)
|
|
cognitive domain - language
Tidsramme: change from baseline after 12 months (aMCI/AD subjects)
|
Fluency score
|
change from baseline after 12 months (aMCI/AD subjects)
|
|
cognitive domain - frontal executive functions
Tidsramme: change from baseline after 12 months
|
Trail Making Test (TMT) score
|
change from baseline after 12 months
|
|
quality of life
Tidsramme: change from baseline after 12 months
|
Dementia Quality of Life (D-QoL) Instrument
|
change from baseline after 12 months
|
|
coping strategies
Tidsramme: change from baseline after 12 months
|
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
|
change from baseline after 12 months
|
|
caregiver quality of life
Tidsramme: change from baseline after 8 weeks and after 12 months
|
Psychological Well-Being (PWB) scale
|
change from baseline after 8 weeks and after 12 months
|
|
caregiver coping strategies
Tidsramme: change from baseline after 8 weeks and after 12 months
|
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
|
change from baseline after 8 weeks and after 12 months
|
|
caregiver burden
Tidsramme: change from baseline after 8 weeks and after 12 months
|
Caregiver Burden Inventory (CBI)
|
change from baseline after 8 weeks and after 12 months
|
|
caregiver affect
Tidsramme: change from baseline after 8 weeks and after 12 months
|
Positive and Negative Affect Schedule (PANAS)
|
change from baseline after 8 weeks and after 12 months
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Samarbeidspartnere
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.
- Realdon O, Rossetto F, Nalin M, Baroni I, Cabinio M, Fioravanti R, Saibene FL, Alberoni M, Mantovani F, Romano M, Nemni R, Baglio F. Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial. BMC Psychiatry. 2016 Nov 25;16(1):425. doi: 10.1186/s12888-016-1132-y.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. april 2015
Primær fullføring (Faktiske)
1. oktober 2016
Studiet fullført (Faktiske)
1. oktober 2016
Datoer for studieregistrering
Først innsendt
12. april 2016
Først innsendt som oppfylte QC-kriteriene
20. april 2016
Først lagt ut (Anslag)
21. april 2016
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
18. januar 2017
Siste oppdatering sendt inn som oppfylte QC-kriteriene
16. januar 2017
Sist bekreftet
1. januar 2017
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- FdG_AD_02
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .